Top Industry Players in India Gabapentin Market | Competitive Landscape & Industry Insights 2026

Top Industry Players in India Gabapentin Market

India Gabapentin Market is characterized by a strong presence of domestic pharmaceutical giants and specialized generic manufacturers, all competing for market share through enhanced formulation R&D and cost-effective production. Major companies in the market include Sun Pharmaceutical Industries Ltd., Cipla Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, and Aurobindo Pharma Limited.

India Gabapentin Market Overview

According to 6Wresearch, the India gabapentin market is expected to increase significantly, fueled by the rising prevalence of neurological disorders and a shift toward non-opioid pain management. The industry is significantly driven by the adoption of generic formulations and a growing elderly population prone to chronic nerve conditions. Furthermore, the integration of extended-release technologies has become a standard for large enterprises in Mumbai and Ahmedabad, as they seek to improve patient adherence and therapeutic outcomes.

Competitive Landscape

The competitive landscape of the India gabapentin market is characterized by high-intensity competition between specialized contract manufacturers and well-established domestic generic leaders. By offering a variety of dosage forms, such as capsules, tablets, and oral solutions, leading companies maintain a dominant market share. Additionally, the market sees frequent collaborations between research-led firms and third-party manufacturers to scale production and meet the rising domestic and export demand for neuropathic treatments.

Below is a list of key players operating in the India Gabapentin Market:

1. Sun Pharmaceutical Industries Ltd.

India’s largest pharmaceutical company, offering high-quality Gabapentin formulations with a strong focus on chronic and neurological care.

2. Cipla Limited

A pioneer in affordable healthcare, providing a wide portfolio of neuro and pain management drugs including Gabapentin generics.

3. Lupin Limited

A key player in CNS and cardiovascular therapies, offering advanced Gabapentin formulations and delivery systems.

4. Glenmark Pharmaceuticals Limited

While strong in dermatology and respiratory, Glenmark also holds a notable position in pain and neurology segments.

5. Aurobindo Pharma Limited

A major exporter of generic Gabapentin, leveraging large-scale production for cost competitiveness.

6. Torrent Pharmaceuticals Ltd.

Renowned for its specialty-driven portfolio, particularly in neurology and cardiovascular therapies.

7. Ipca Laboratories Limited

Provides high-quality APIs and finished formulations for neuropathic pain and CNS disorders.

8. Abbott India Limited

Offers premium branded Gabapentin products backed by global clinical expertise and strong brand trust.

9. Alkem Laboratories Limited

Known for its strong domestic presence and diversified portfolio of anti-epileptic and analgesic medicines.

10. Intas Pharmaceuticals Ltd.

A vertically integrated pharma company with a strong footprint in neuro-psychiatry and global generics.

11. Micro Labs Limited

A leading manufacturer of pain management drugs with advanced manufacturing facilities.

12. Strides Pharma Science Limited

Focuses on niche generics and has expanded its neurology portfolio with high-strength Gabapentin approvals.

13. Systole Remedies

A contract manufacturer specializing in Gabapentin formulations and private labeling services.

14. Centurion Remedies Private Limited

A major exporter offering combination therapies such as Gabapentin with Nortriptyline.

15. Pfizer Inc. 

The original developer of Neurontin, maintaining strong brand trust and clinical recognition in India’s neurology market.

Top Industry Players in India Gabapentin Market 2026 : FAQs